Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies.
- Author:
Yan ZHU
1
;
Shu-ping CHEN
;
Yi-gang SHU
;
Ya-jing XU
Author Information
1. Department of Hematology, Xiangya Hospital, Central South University, Changsha 410008, China. zhuyanlq@hotmail.com
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Aged;
Antifungal Agents;
therapeutic use;
Aspergillosis;
complications;
diagnosis;
drug therapy;
Candidiasis;
complications;
diagnosis;
drug therapy;
Female;
Fluconazole;
therapeutic use;
Hematologic Neoplasms;
microbiology;
Humans;
Itraconazole;
therapeutic use;
Lung Diseases, Fungal;
complications;
diagnosis;
drug therapy;
Male;
Middle Aged
- From:
Journal of Central South University(Medical Sciences)
2008;33(1):89-92
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the clinical features of invasive fungal infection in patients with hematological malignancies and to compare the the therapeutic effect of fluconazole and intraconazole.
METHODS:The clinical manifestations, mycological features, and the therapeutic results of 47 patients were retrospectively analyzed. Fluconazole was given to 17 paitents, intraconazole was given to 21 patients, and intraconazole to the other 9 patients after they had no effect with fluconazole.
RESULTS:All patients had fever. The lung and the mouth cavity were the main locations of infection (53.2% and 21.3%, respectively). Fungi were found in 23 (48.9%) patients, in which the majority were Candida albicans and Aspergillus (56.5% and 26.1%, respectively). Intraconazole was more effective than fluconazole (63.3% vs. 34.6%, P<0.05) with no serious side effect.
CONCLUSION:The most common clinical features of IFI are fever, lung infection, and oral infection in patients with hematological malignancies. Candida albicans and Aspergillus infection are common. Intraconazole is safe and effective for invasive fungal infection.
